Moderna’s Product Revenue by Region (2021-2022)

You need Pro Plan to access KPI data.

Get 60% off on Pro

Discount ends in:

00
Days
00
Hours
00
Mins.
00
Seconds

.

About

This statistic highlights Moderna’s Product Revenue by Region from Q1 2021 onwards, split between the United States and the rest of the world.
Subscribe to Pro or Enterprise plans to unlock this feature.
More information

Subscribe to Pro or Enterprise plans to unlock this feature.

Contact the Analyst

Subscribe to Pro or Enterprise plans to unlock this feature.

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on reddit
Share on facebook
Share on twitter
Share on linkedin
Share on email

Become a smarter investor today.

Access Business Quant for as low as $19/month

Become a smarter investor today.

Access KPIs & Segment Financials on US stocks

This statistic highlights Moderna’s Product Revenue by region, split between the United States and the rest of the world, reported on a quarterly basis from Q1 2021 onwards.

Moderna’s major market for supplying their COVID-19 vaccine has been the United States. Gradually, they also began their international sales. WHO and other health agencies authorized the use of their vaccine in over fifty countries. In early 2021, the company declared that they would be supplying their vaccines to 92 low and middle-income countries in Q4 2021 through COVAX. They also received authorization for their COVID-19 vaccine for adolescent use in the European Union, countries like the United Kingdom, Japan, Switzerland, Canada, Saudi Arabia, Taiwan, Philippines, and Australia. For supplying this vaccine, they entered into supply agreements with not only the United States but also UNICEF and the African Union– agreeing to sell approximately 110 million vaccines to African countries in October, 2021.

Moderna’s Product Revenue by Region

Revenue by region  Q1 2021  Q2 2021  Q3 2021
Rest of world 375 2,104 3,613
United States 1,358 2,093 1,197
Total 1,733 4,197 4,810

(All figures are in millions)

Moderna’s Revenue Contribution by Region

Revenue Contribution by region  Q1 2021  Q2 2021  Q3 2021
United States 78.36% 49.87% 24.89%
Rest of world 21.64% 50.13% 75.11%

There is a gradual rise in the total revenue with every quarter. Q1 2021 recorded $1,733 million being the lowest of the three quarters. The latest quarter (Q3 2021) recorded the highest total of $4,810 million. Furthermore, the company earned $1,197 million sales revenue from the United States and $3,613 million from foreign sales — thereby amounting to a total of $4,810 million split into 24.89% and 75.11%  between US and foreign sales respectively. What we can infer from this data is that Moderna’s product sales were mainly concentrated in the States. International sales were relatively slimmer with the company focusing on the US as its primary market.

In comparison to Q2 2021; Moderna’s total revenue increased from $4,197  to $4,810 in Q3 2021 marking a 14.61% growth on a quarter-on-quarter basis, owing to the surge in the sale of their product. The company delivered about 73 million doses of their COVID-19 vaccine in the United States along with around 136 million doses to international countries. Total revenue for 9 months till September 30, 2021, increased by $11 billion as compared to the same period of the previous year—this is because of the increase in product sales and grant revenue. For this period, Moderna delivered about 287 million doses to the United States and about 222 million doses to foreign governments. 

About Moderna Inc. 

Moderna, Inc. was incorporated in 2016 in Delaware. Working in the field of biotechnology, their work of new transformative medicine creation is based on messenger RNA that aims to improve patient lives. They operate in a reporting segment that largely focuses on the commercialization of mRNA medicines including its discovery and subsequent development. Their platform is structured to build on constant developments in mRNA science, manufacturing, and delivery technology. In 2020, they received authorization for their COVID-19 vaccine from the WHO and other health organizations and agencies in several countries. This is their only commercial product authorized for use.

Did you like Moderna’s Product Revenue by Region statistic?

Access thousands of more such key performance indicators, on thousands of listed companies, with Business Quant.

You can get started here.

Read more

Our Plans

Always know what you’ll pay. No hidden costs or surprises.

  • Annual
  • Monthly

Basic

Get to know us

  • Access basic data
  • No credit card required
$0
per month
Start for Free

60% discount until June 30

Pro

For serious investing

  • Granular KPI data Access segment financials, non-GAAP metrics and KPI data from presentations and filings. Examples include financials by segment / region / product category, AT&T's broadband subscriber trends, Tesla's deliveries by model and lots more.
  • Stock research tools Features include : Stock screener, Stock comparison, sector financials, stock warnings, advanced charting tools, financial statements dating back 10+ years, stock reports, SEC filings and stock ratings. There are 200+ financial items and ratios on thousands of US stocks.
  • Industry data & tools Access premium operating data on 40+ industries. Examples include market share, smartphone shipments by vendor, subscribers by wireless carrier, historical gold production. There are 20,000+ such statistics.
$49
$19
per month*
Buy Now

Enterprise

For tailored workflows

  • All of Pro plan Get unfettered access to all our dashboards and dossiers.
  • Custom built features Get tailored dashboards built specially for you , based on your set of requirements, to simplify your research workflow.
$99
per month, onwards*
Contact Us

* Billed annually, local taxes extra. 

Basic

Get to know us

  • Access basic data
  • No credit card required
$0
per month
Start for Free

60% discount on Annual plan

Pro

For serious investing

  • Granular KPI data Access segment financials, non-GAAP metrics and KPI data from presentations and filings. Examples include financials by segment / region / product category, AT&T's broadband subscriber trends, Tesla's deliveries by model and lots more.
  • Stock research tools Features include : Stock screener, Stock comparison, sector financials, stock warnings, advanced charting tools, financial statements dating back 10+ years, stock reports, SEC filings and stock ratings. There are 200+ financial items and ratios on thousands of US stocks.
  • Industry data & tools Access premium operating data on 40+ industries. Examples include market share, smartphone shipments by vendor, subscribers by wireless carrier, historical gold production. There are 20,000+ such statistics.
$49
per month*
Buy Now

Enterprise

For tailored workflows

  • All of Pro plan Get unfettered access to all our features.
  • Custom built features Get tailored dashboards built specially for you , based on your set of requirements, to simplify your research workflow.
$99
per month, onwards*
Contact Us

* Local taxes extra. 

BQ Star Yellow 60%

Get Pro for 60% off

  • Access all features immediately
  • Datasets updated every day
  • Export data in CSV and XLSX formats

Offer Ends In

Starting from $49 $19 / month

.